Tonix Medicines, Inc. /
Upsher-Smith Laboratories, LLC
Tonix Medicines Completes Purchase of Two Migraine Products
- Price
- $15m
- Stage
- Closed
What happened
Tonix Medicines, Inc. completed its acquisition of assets related to Zembrace SymTouch and Tosymra from Upsher-Smith Laboratories, LLC. The products are indicated for treating acute migraine in adults.
Consideration included $15 million in cash and $10 million for Business-related inventories.
The source
Everything on this page comes from the source below.
Tonix Medicines Completes Purchase of Two Migraine Products
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly